Coq10 and Peripheral vascular disorder - a phase IV clinical study of FDA data
Summary:
Peripheral vascular disorder is reported as a side effect among people who take Coq10 (coenzyme q - 10), especially for people who are female, 60+ old, also take Vicodin, and have Anaemia.
The phase IV clinical study analyzes which people have Peripheral vascular disorder when taking Coq10. It is created by eHealthMe based on reports of 9,269 people who have side effects when taking Coq10 from the FDA, and is updated regularly.
What is Coq10?
Coq10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 10,401 Coq10 users. Check the latest studies of Coq10.
What is Peripheral vascular disorder?
Peripheral vascular disorder is found to be associated with 784 drugs and 758 conditions by eHealthMe. Check the latest studies of Peripheral vascular disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
9,269 people reported to have side effects when taking Coq10.
Among them, 17 people (0.18%) have Peripheral vascular disorder.

Among these 17 people:
What is the gender of people who have Peripheral vascular disorder when taking Coq10? *
- female: 56.25 %
- male: 43.75 %
What is the age of people who have Peripheral vascular disorder when taking Coq10? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 6.67 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 93.33 %
What are other drugs people take besides Coq10? *
- Zometa: 15 people, 88.24%
- Aredia: 15 people, 88.24%
- Vicodin: 15 people, 88.24%
- Prilosec: 11 people, 64.71%
- Lasix: 9 people, 52.94%
- Ocuflox: 9 people, 52.94%
- Aromasin: 9 people, 52.94%
- Neurontin: 9 people, 52.94%
- Nabumetone: 9 people, 52.94%
- Celebrex: 9 people, 52.94%
What are other side effects people have besides Peripheral vascular disorder? *
- Pain: 16 people, 94.12%
- Bone Disorder: 15 people, 88.24%
- Stress And Anxiety: 15 people, 88.24%
- Intervertebral Disc Protrusion (spinal disc protrusion): 15 people, 88.24%
- Polyp: 15 people, 88.24%
- Blood Creatinine Increased: 14 people, 82.35%
- Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 70.59%
- Constipation: 10 people, 58.82%
- Seborrhoeic Keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest): 10 people, 58.82%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 58.82%
What are the existing conditions these people have? *
- Anaemia (lack of blood): 9 people, 52.94%
- Hypercalcaemia (elevated calcium (ca+) level in the blood): 8 people, 47.06%
- Prostatitis (inflammation of the prostate gland): 6 people, 35.29%
- Multiple Myeloma (cancer of the plasma cells): 6 people, 35.29%
- Type 2 Diabetes: 1 person, 5.88%
- Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 5.88%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%
- Bipolar Disorder (mood disorder): 1 person, 5.88%
- Asthma: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Coq10 and have Peripheral vascular disorder?
- Check whether Peripheral vascular disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Coq10:
- Coq10 (10,401 reports)
Peripheral vascular disorder treatments and more:
- Peripheral vascular disorder (10,004 reports)
How severe was Peripheral vascular disorder and when was it recovered:
Expand to all the drugs that have ingredients of coenzyme q - 10:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Coq10:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Peripheral vascular disorder:
- Peripheral vascular disorder (784 drugs)
Browse all the conditions that are associated with Peripheral vascular disorder:
- Peripheral vascular disorder (758 conditions)
Related publications that referenced our studies
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on coenzyme q - 10 (the active ingredients of Coq10) and Coq10 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ambisome and Arrhythmias for Girls aged 10-19 - 12 seconds ago
- Ambisome and Tachycardia for Girls aged 10-19 - 12 seconds ago
- Ambisome and Dysrhythmias for Girls aged 10-19 - 12 seconds ago
- Ambisome and Abnormal Heart Rhythms for Girls aged 10-19 - 12 seconds ago
- Ambisome and Arrhythmia for Girls aged 10-19 - 13 seconds ago
- Fexofenadine Hydrochloride Allergy vs. Hydroxyzine Pamoate, side effect and effectiveness comparison - 17 seconds ago
- Could Gabapentin cause Injection Site Abscess? - 19 seconds ago
- Could Gabapentin cause Glossitis? - 24 seconds ago
- Barrett'S Oesophagus and Depression - 30 seconds ago
- Methylphenidate and Temaz drug interactions for men aged 60+ - 34 seconds ago